Core Viewpoint - Baiaosaitu (Beijing) Pharmaceutical Technology Co., Ltd. has received approval for its initial public offering (IPO) of ordinary shares in RMB and listing on the Sci-Tech Innovation Board [1] Group 1: Company Information - The issuer is Baiaosaitu (Beijing) Pharmaceutical Technology Co., Ltd. [1] - The main underwriter for the IPO is China International Capital Corporation Limited [1] Group 2: Regulatory Approval - The application for the IPO has been approved by the Sci-Tech Innovation Board Committee of the Shanghai Stock Exchange [1] - The registration has been authorized by the China Securities Regulatory Commission (CSRC) under license number 2025〔2296〕 [1] Group 3: Disclosure Information - The prospectus for the IPO is available on the Shanghai Stock Exchange website and other specified platforms [1] - The prospectus can also be accessed at the issuer's location and that of the main underwriter [1]
百奥赛图（北京）医药科技股份有限公司首次公开发行股票并在科创板上市招股说明书提示性公告